James Mock
Net worth: 3 M $ as of 31/05/2026
Net worth: 3 M $ as of 31/05/2026
James M. Mock is Chief Financial Officer & Senior Vice President for PerkinElmer, Inc. (United States). He previously was Vice President at General Electric Co. and Chief Financial Officer & Vice President at GE Oil & Gas, Inc. (a subsidiary of General Electric Co.). He received an undergraduate degree from St. Lawrence University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MODERNA, INC. 0.02% | 05/06/2026 | 65,687 ( 0.02% ) | 3 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| MODERNA, INC. | Director of Finance/CFO | 06/09/2022 |
| Companies | Position | End |
|---|---|---|
| REVVITY, INC. | Director of Finance/CFO | 05/09/2022 |
| GE AEROSPACE | Corporate Officer/Principal | 01/04/2018 |
Baker Hughes Energy Services LLC
Baker Hughes Energy Services LLC Industrial MachineryProducer Manufacturing Manufactures and supplies blower and compressor technologies | Director of Finance/CFO | 01/01/2015 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
GE Aerospace
GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
St. Lawrence University
St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baker Hughes Energy Services LLC
Baker Hughes Energy Services LLC Industrial MachineryProducer Manufacturing Manufactures and supplies blower and compressor technologies | Producer Manufacturing |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions